Products
All products
Export catalog
Standards
Development
Pharmacovigilance
About
About us
Strategy
To partners
Contacts
Press Center
News
Events
Publications
Blog
Products
Partners
Development
Standards
About us
About Pharmland
Strategy
News
Contacts
En
Ру
En
Ру
Menu
Products
Partners
Development
Standards
About us
About Pharmland
Strategy
News
Contacts
En
Ру
Home
/
Products
Medications
Release form
- Any -
Capsules
Chewable tablets
Concentrate for solution for infusion
Drops
Intravenous solution
Irrigation solution
Liquid for inhalation anesthesia
Lozenges
Lyophilisate for preparation of solution for infusion
Powder
Powder for preparing a solution for intravenous use
Solution for external use
Solution for infusion
Solution for internal use
Spray
Suspension
Syrup
Tablet
Tablets for solution preparation
Vaginal tablet
Appointment
- Any -
Anti-inflammatory and analgesic
Anti-inflammatory therapy
Sale terms
- Any -
Without prescription
On prescription
ATC
- Any -
A03FA. Stimulants of gastrointestinal motility
A06A. Laxatives
A07BC05. Other intestinal adsorbents
A10B. Oral hypoglycemic drugs
A11СС05. Vitamins. Vitamin D and its analogues.
A12A. Calcium preparations
A12C. Magnesium preparations
A16AA. Amino acids and their derivatives
B02AB. Fibrinolysis inhibitors
B03A. Iron preparations
B03AB. Iron preparations 3+ for oral use
B03AD. Iron supplements in combination with folic acid
B05AA. Blood plasma preparations and plasma-substituting drugs
B05BA. Parenteral nutrition solutions
B05BB. Solutions affecting the water-electrolyte balance
B05BC. Osmodiuretic solutions
B05CX. Other irrigation solutions
B05XA. Electrolyte solutions
C01A. Cardiac glycosides
C01C. Cardiotonic agents, except cardiac glycosides
C01E. Other drugs for the treatment of heart disease
C03A. Thiazide diuretics
C03B. Non-thiazide diuretics
C04A. Peripheral vasodilators
C05C. Other drugs that reduce capillary permeability
C07A. Beta-blockers
C08D. Selective calcium channel blockers with a direct effect on cardiomyocytes
C09A. ACE inhibitors
C09B. ACE inhibitors in combination with other drugs
C09C. Angiotensin II antagonists
D08A. Antiseptics and disinfectants
D08AX. Other antiseptic and disinfectants. Sodium hypochlorite.
D1AX. Other dermatological drugs
G01A. Antiseptics and antimicrobial drugs for the treatment of gynecological diseases
G04BE. Drugs for the treatment of erectile dysfunction
H05B. Antiparathyroid medicines
J01CA04. Beta-lactam antibacterial agents for systemic use. Penicillins
J01CR02. Beta-lactam antibacterial agents for systemic use. Combinations of penicillins, including beta-lactamase inhibitors
J01DB. First generation cephalosporins
J01DH02. Antibacterials for systemic use. Other beta-lactam antibacterials. Carbapenems.
J01F. Macrolides, lincosamides and streptogramins
J01FA. Antibacterial agents for systemic use. Macrolides.
J01M. Antimicrobials - Quinolone Derivatives
J01MA. Fluoroquinolones
J01XD. Imidazole derivatives
J01XX - Other antibacterial agents
J02A. Antifungal drugs for systemic use
J02AC. Triazole derivatives
J05A. Direct-acting antiviral drugs
J05AP. Antiviral drugs for the treatment of hepatitis C
L02B. Hormone antagonists and their analogues
M01A. Non-steroidal anti-inflammatory drugs
M01AX. Other non-steroidal anti-inflammatory drugs
M04AA. Uric acid formation inhibitors
N01A. General anesthetics
N01BA. Esters of aminobenzoic acid
N02BE. Other analgesics and antipyretics
N02BE. Paracetamol in combination with other drugs
N03A. Antiepileptic drugs
N03AX. Other antiepileptic drugs
N05CM09. Other hypnotics and sedatives
N06AA. Antidepressants. Non-selective monoamine reuptake inhibitors.
N06B. Psychostimulants and nootropics
N06B. Psychostimulants, drugs for the treatment of attention deficit hyperactivity disorder and nootropics
N07X. Drugs for the treatment of diseases of the nervous system
P02C. Drugs for the treatment of nematodosis
P02CC. Tetrahydropyrimidine derivatives
R01AA. Decongestants and other agents for topical application in rhinology. Sympathomimetics.
R02AA. Medicines for the treatment of the larynx and pharynx. Antiseptics.
R05C. Expectorants drugs
R05CA. Expectorant combination drugs
R06A. Systemic antihistamines
S01A. Antimicrobial drugs
S01XA. Other drugs for the treatment of eye diseases
V07AB. Solvents and dilution solutions, including irrigation solutions
N06BX. Other psychostimulants and nootropic drugs
А02AX. Other combinations of antacids
В01А. Anticoagulants
С08С. Selective calcium channel blockers with a predominant effect on blood vessels
С08СА. Selective calcium channel blockers with a predominant effect on blood vessels
Применить
Grid view
Table view
Diclofenac
